Passage BIO, Inc. — Director's Dealing 2021

Feb 19, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Passage BIO, Inc. (PASG)
CIK: 0001787297
Period of Report: 2021-02-16

Reporting Person: Fotopoulos Alexandros (Chief Technical Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-02-16	Stock Option (right to buy)	$21.85	A	105000	Acquired	2031-02-15	Common Stock (105000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	6888	Direct

Footnotes

F1: Reflects 2020 Employee Stock Purchase Plan allocations of 1,388 shares that occurred since the date of the reporting person's last ownership report.

F2: The stock option vests as to 25% of the total shares on February 16, 2022, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.